Publication
Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group
Sotirios G. Papageorgiou, Ioannis Kotsianidis, Christos K. Kontos, Argyris Symeonidis, Athanasios Galanopoulos, Eleftheria Hatzimichael, Elias Poulakidas, Panagiotis Diamantopoulos, Theodoros P. Vassilakopoulos, Panagiotis Zikos, Helen Papadaki, Eleni Bouronikou, Panayiotis Panayiotidis, Nora-Athina Viniou, Vasiliki Pappa
Leukemia Research, August 2018, Elsevier
DOI: 10.1016/j.leukres.2018.07.004